Treatment Indications: correction of deep mimic wrinkles and severe facial folds (nasolabial folds, forehead lines, marionette lines);, facial volumetry and contouring (cheeks, temples, chin, jawline);, non-surgical rhinoplasty and nasal ridge refinement;, restoration of pronounced volume deficits and facial skeletal support;
Release form: 1 × 1.0 mL pre‑filled sterile glass syringe
Indications: subdermal and supraperiosteal injection for correction of deep wrinkles, folds, and severe volume deficits;, high‑viscosity gel with particle size ~420 μm;, utilizing Multi‑staged Cross‑Linking (MCL) technology and MDM Filler™ platform for maximum shape retention, cohesivity, and lifting power;, ensuring stable projection, even tissue integration, and minimal migration with low osmolarity (~280–300 mOsm/L) to minimize post-procedural swelling (effect duration ~12–18 months)